scholarly journals Do Evidence-Based Treatments for Circadian Rhythm Sleep-Wake Disorders Make the GRADE? Updated Guidelines Point to Need for More Clinical Research

2015 ◽  
Vol 11 (10) ◽  
pp. 1079-1080 ◽  
Author(s):  
R. Robert Auger ◽  
Helen J. Burgess ◽  
Jonathan S. Emens ◽  
Ludmila V. Deriy ◽  
Katherine M. Sharkey
Keyword(s):  
Circadian Rhythm ◽  
Clinical Research ◽  
Evidence Based ◽  
Sleep Wake Disorders ◽  
Evidence Based Treatments

Management of insomnia and circadian rhythm sleep–wake disorders

2020 ◽  
pp. 1167-1178
Author(s):  
Simon D. Kyle ◽  
Alasdair L. Henry ◽  
Colin A. Espie
Keyword(s):  
Circadian Rhythm ◽  
Evidence Based ◽  
Sleep Wake Disorders ◽  
Insomnia Disorder ◽  
Cognitive Behavioural ◽  
Melatonin Administration ◽  
Evidence Based Treatments ◽  
Rhythm Disorder ◽  
Delayed Sleep ◽  
Behavioural Therapies

Insomnia disorder and circadian rhythm sleep–wake disorders (CRSWDs) are prevalent and impairing sleep disorders and often co-present with psychiatric disorder. Insomnia is characterized by difficulty with initiation and/or maintenance of sleep, driven primarily by cognitive behavioural processes. CRSWDs manifest because of alterations to the endogenous circadian clock (intrinsic) or as a consequence of environmental circumstances (extrinsic). This chapter reviews evidence-based treatments for the management of insomnia and intrinsic CRSWDs (delayed sleep–wake phase disorder, advanced sleep–wake phase disorder, non-24-hour sleep–wake disorder, irregular sleep–wake rhythm disorder). The chapter covers cognitive behavioural therapies, sleep-promoting hypnotics, phototherapy, and exogenous melatonin administration. The chapter also highlight gaps in the existing clinical science and reflects on emergent therapeutic approaches.

Evidence-Based Alcohol and Substance Use Disorder Treatment with Sexual and Gender Minorities

2019 ◽  
pp. 222-243
Author(s):  
Adam W. Carrico ◽  
Walter Gómez ◽  
Cathy J. Reback
Keyword(s):  
Substance Use ◽  
Clinical Research ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Evidence Based ◽  
Sexual Minority Women ◽  
Substance Use Disorder Treatment ◽  
Evidence Based Treatments ◽  
Disorder Treatment ◽  
And Gender

Although sexual and gender minority (SGM) populations remain at markedly elevated risk for developing alcohol and substance use disorders, relatively few substance use disorder treatment programs provide culturally tailored services. This chapter provides an overview of alcohol and substance use disparities as well as reviews evidence-based interventions in distinct SGM populations. In general, clinical research has focused on culturally tailoring evidence-based substance use disorder treatments such as cognitive–behavioral therapy and motivational interviewing with modest success. Further clinical research should develop and test novel substance use disorder intervention approaches that address minority stress processes as key triggers for unhealthy alcohol consumption and substance use. Clinical research is also needed to address the disparities in unhealthy drinking among sexual minority women as well as alcohol and substance use disparities in transgender individuals. Recommendations are provided to optimize the effectiveness and scalability of existing evidence-based treatments targeting alcohol and substance use disorders in SGM populations.

Refining Evidence-Based Treatments for Late-Life Depression

GeroPsych ◽  
2015 ◽  
Vol 28 (2) ◽  
pp. 67-76
Author(s):  
Grace C. Niu ◽  
Patricia A. Arean
Keyword(s):  
Older Adults ◽  
Mental Illness ◽  
Brain Plasticity ◽  
Late Life ◽  
Aging Population ◽  
The United States ◽  
Future Research ◽  
Evidence Based ◽  
Late Life Depression ◽  
Evidence Based Treatments

The recent increase in the aging population, specifically in the United States, has raised concerns regarding treatment for mental illness among older adults. Late-life depression (LLD) is a complex condition that has become widespread among the aging population. Despite the availability of behavioral interventions and psychotherapies, few depressed older adults actually receive treatment. In this paper we review the research on refining treatments for LLD. We first identify evidence-based treatments (EBTs) for LLD and the problems associated with efficacy and dissemination, then review approaches to conceptualizing mental illness, specifically concepts related to brain plasticity and the Research Domain Criteria (RDoc). Finally, we introduce ENGAGE as a streamlined treatment for LLD and discuss implications for future research.

Sign in / Sign up

Export Citation Format

Share Document